Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Gritstone Oncology, Inc. (GRTS)  
$0.78 0.01 (1.91%) as of 4:30 Tue 6/18


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 67,990,000
Market Cap: 52.71(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.7031 - $2.9
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gritstone bio is a biotechnology company developing targeted immunotherapies for cancer and infectious disease. Co. discovers, develops, manufactures, and delivers cancer and infectious disease immunotherapy candidates by utilizing both of its vaccine vectors, self-amplifying mRNA and chimpanzee adenovirus. Co.'s oncology programs in clinical stage development are GRANITE, an individualized neoantigen-based immunotherapy, and SLATE, an off-the-shelf shared neoantigen-based immunotherapy. Co.'s programs in clinical stage development are: CORAL, a second generation COVID-19 vaccine program and an HIV therapeutic/cure vaccine candidate that Co. is collaborating on with Gilead Sciences, Inc.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 12,000
Total Buy Value $0 $0 $0 $22,829
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 74,769 74,769 74,769 74,769
Total Sell Value $55,949 $55,949 $55,949 $55,949
Total People Sold 5 5 5 5
Total Sell Transactions 5 5 5 5
End Date 2024-03-21 2023-12-19 2023-06-20 2022-06-20

   
Records found: 85
  Page 4 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Jones Erin See Remarks   •       –      –    2019-01-29 4 OE $0.35 $3,450 D/D 10,000 10,000     -
   Green Jeremy 10% Owner   –       –       •   2018-10-02 4 A $0.00 $0 I/I 1,394,529 1,394,529     -
   Versant Affiliates Fund V, L.p. general partner   –       –      –    2018-10-02 4 A $0.00 $0 I/I 3,102,929 3,102,929     -
   Simon Nicholas Director   –       •       •   2018-10-02 4 A $0.00 $0 I/I 2,234,112 2,567,445     -
   Clarus Ventures Iii, Llc General Partner   –       –      –    2018-10-02 4 A $0.00 $0 D/D 2,234,112 2,567,445     -
   Goeddel David V Managing Partner   –       –      –    2018-10-02 4 A $0.00 $0 D/D 3,102,934 3,102,934     -
   Svennilson Peter Director   –       •       •   2018-10-02 4 A $0.00 $0 I/I 3,102,934 3,102,934     -
   Woiwode Thomas Director   –       •       •   2018-10-02 4 A $0.00 $0 I/I 3,102,929 3,102,929     -
   Simon Nicholas Director   –       •       •   2018-09-28 4 B $15.00 $4,999,995 I/I 333,333 333,333 2.25     -
   Clarus Ventures Iii, Llc General Partner   –       –      –    2018-09-28 4 B $15.00 $4,999,995 D/D 333,333 333,333 2.44     -

  85 Records found
  1  2  3  4    
  Page 4 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed